|
|
|
Corporate Profile: Portola Pharmaceuticals
| Summary: |
| Portola Pharmaceuticals is focused on developing therapeutics for the treatment of cardiovascular disease and inflammation. |
| Address (HQ): |
270 E. Grand Avenue
South San Francisco, CA 94080 |
| Phone #'s (HQ): |
| Main |
(650) 246-7000 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(650) 246-7376 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| PTLA |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
